BTIG sees 'incremental positives' in Rezolute (RZLT) regulatory update

March 24, 2026 3:40 PM

BTIG analyst Julian Harrison reiterated a Buy rating and $5.00 price target on Rezolute (NASDAQ: RZLT)The analyst commented, "The FDA ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found